Myocardial Dysfunction With Contemporary Management of HIV: Prevalence, Pathophysiology, and Opportunities for Prevention

JACC Heart Fail. 2019 Feb;7(2):109-111. doi: 10.1016/j.jchf.2018.12.004.

Authors

Christopher R deFilippi¹, Steven K Grinspoon²

Affiliations

¹ Inova Heart and Vascular Institute, Falls Church, Virginia. Electronic address: [email protected].
² Program in Nutritional Metabolism, Division of Endocrinology, Massachusetts General Hospital, and Harvard Medical School, Boston, Massachusetts.

PMID: 30704602
DOI: 10.1016/j.jchf.2018.12.004

No abstract available

Keywords: HIV; antiretroviral therapy; immune activation; major adverse cardiovascular events.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Cardiomyopathies*
HIV Infections*
Heart Diseases*
Heart Failure*
Humans
Prevalence